CRISPR/Cas9 for the treatment of haematological diseases: a journey from bacteria to the bedside.
Saved in:
| Title: | CRISPR/Cas9 for the treatment of haematological diseases: a journey from bacteria to the bedside. |
|---|---|
| Authors: | Humbert O; Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Samuelson C; Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Kiem HP; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; University of Washington School of Medicine, Seattle, WA, USA. |
| Source: | British journal of haematology [Br J Haematol] 2021 Jan; Vol. 192 (1), pp. 33-49. Date of Electronic Publication: 2020 Jun 07. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2141 |
|---|---|
| DOI: | 10.1111/bjh.16807 |
